Contact Us: 1-800-708-8800
Facebook and Twitter and Gift Card
   
 
 
     
 
 
  Doylestown, PA  
  Phone: 215-230-9200
     
  Hopewell, NJ  
  Phone: 609-882-8833
     
  Hamilton, NJ  
  Phone: 609-890-0772
   
  Toll Free:1-800-708-8800
   
 

  • news
  • events
 

Interesting Facts about Human Eyes

 
Interesting Facts about Human Eyes 1) Eyes are composed of more than 2 million workin  read full article 
   
 

Pet Vision

 
Pet Vision Do you ever wonder if your pet sees the same things with the same detail th  read full article 
   
 

February is Age Related Macular Degeneration Awareness Month

 
February is Age Related Macular Degeneration Awareness Month Doylestown, PA - February   read full article 
   
 

Local Artist Program, Featuring Shirley Broad

 
Local Artist Program, Featuring Shirley Broad Matossian Eye Associates launched its Local   read full article 
   
 
Tuesday, May 28, 2013
 
06:30 PM To 08:00 PM
 
Cynthia Matossian, MD is presenting a free community presentation at the V.I.A. Auditorium in the He
view event
   

Our Doyelstown Office is Moving!

Posted on: Friday, September 30, 2011
Author: Matossian Eye Associates

Tags: office move, address

We will be moving our Doylestown Office this weekend!  Starting on Monday, October 3rd, we will be seeing patients at the new location.  Please update your records to reflect our new address:  501 Hyde Park, Route 202, Doylestown, PA 18902.

What Ever Happened to Dilation Reversal Drops?

Posted on: Thursday, September 29, 2011
Author: Matossian Eye Associates

Tags: eye exam, dialation, dapiprazole, pupil constriction

Pupillary dilation is a crutial part of your eye exam, and a most valuable step toward protecting your eye health.  But it is also greatly disliked by most patients.  Dilation drops typically take 4-6 hours to wear off, and during that time blurred vision and light sensitivity remain.  Released in 1991, Rev-Eyes (dapiprazole), promised to revolutionize the practice of eye care by providing a means to reverse dilation.  The new drop counteracted dilation by stimulating pupil constriction.  The reality of the situation was that the drop tended to work slow, often taking a few hours to return pupils to their normal state.  The drop also caused unpleasant side effects such as stinging upon instillation and red eyes in the majority of patients.  It was also expensive, costing 4-5x more than the dilation drops.  Rev-Eyes are no longer available in the United States, but hope remains for an alternative.   
 
Rebecca Mueller, O.D.
 

 

 

Eye Bling

Posted on: Tuesday, September 27, 2011
Author: Matossian Eye Associates

Tags: eye diamonds, contact lenses, gold plated, scleral lenses, india

 

Priced at a whopping $15K are the worlds first gold plated and diamond studded contact lenses.  Inspired by an optometrist in India, this eye jewelry has been developed through the Shekhar Eye Institute.  Eye care professionals are not without concern, as these large "scleral" lenses are bulky and typically used only when necessary to treat diseased eyes.  Luckily the price tag is sure to sway most beauty addicts.   
 
Rebecca Mueller, OD

Electronically Focusing Eyeglasses.

Posted on: Thursday, September 22, 2011
Author: Matossian Eye Associates

Tags: prescription eyeglasses, electronically focusing.

 
Recently eye doctors in Phoenix got a sneak peek at the world's first and only electronically-focusing prescription eyeglasses according to KPHO.  The new eyeglasses are called Empower glasses. The glasses created by Pixel Optics change focus when the wearer touches his temple or tilts his head instantly creating an up close or near zone.  The glasses are powered by a hidden battery that is rechargeable.  The new eyeglasses are supposed to have less distortion and wider field of views as compared to progressive glasses.
 
Jennine Lutz, O.D.

Saving Sight in Preemies.

Posted on: Wednesday, September 21, 2011
Author: Matossian Eye Associates

Tags: retinopathy of prematurity, rop, preemies, blindness, avastin, retina

According to the Phoenix Business Journal a new treatment to prevent blindness from Retinopathy of Prematurity (ROP) in premature infants was performed in Scottsdale, Arizona.  ROP is one of the most common causes of visual loss in children.  This new treatment uses the cancer drug Avastin.  The Avastin is injected directly into the eye to reverse the effects from the ROP.  The alternate treatment is laser which has been used for years, but can cause damage to eyes and is not always 100% successful.

 
Dr. James Plotnik, consulting pediatric ophthalmologist at Scottsdale Healthcare, injected avastin into a preemie with ROP and the retinas now look completely normal.  Although he states this is still early on he is very optimistic that the infant will have normal vision.  According to a study published in the New England Journal of Medicine it was stated that Avastin is far more effective at preventing blindness in preemies than laser.
 
Jennine Lutz, O.D.
|1| 2 3 | Next >>

Blog Home

Recent Posts


Featured Articles


Categories


Tags



Archives



RSS:    RSS Feed
 
Home    About Us    Services    Cataract Surgery    Glaucoma    Contact Lenses   Products    Testimonials
News   Event    Recommended Links    Privacy Notice/Forms    Educational Videos    Eye Problems    Contact Us
 
© Copyright 2013 Matossian Eye Associates. All Rights Reserved.
 
Doylestown, PA
501 Hyde Park
PA, 18902
Phone: 215-230-9200
Fax: 215-230-9292
Hopewell, NJ
Two Capital Way
Suite 326
Pennington, NJ 08534
Phone: 609-882-8833
Fax: 609-882-0077
Hamilton, NJ
1445 Whitehorse-Mercerville Rd
Suite 106, NJ, 08619
Phone: 609-890-0772
Fax: 609-890-0774
Facebook Twitter Gift Card